Endocrinologia Clinica - Vilar 6 edicao_Parte1052

Prévia do material em texto

23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
Begum-Hasan J, Polychronakos C, Brill H. Familial permanent neonatal diabetes with KCNJ11 mutation and the response to
glyburide therapy – a three-year follow-up. J Pediatr Endocrinol Metab. 2008; 21:895-903.
Molven A, Ringdal M, Nordbø AM et al. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1
diabetes. Diabetes. 2008; 57:1131-5.
Laugesen E, Østergaard JA, Leslie RD; Danish Diabetes Academy Workshop and Workshop Speakers. Latent autoimmune
diabetes of the adult: current knowledge and uncertainty. Diabet Med. 2015; 32:843-52.
Naik RG, Palmer JP. Latent autoimmune diabetes in adults (LADA). Rev Endocr Metab Disord. 2003; 4:233-41.
Calsolari MR, do Rosário PW, Reis JS et al. Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus? Arq Bras
Endocrinol Metabol. 2008; 52:315-21.
Libman IM, Becker DJ. Coexistence of type 1 and type 2 diabetes mellitus: “double” diabetes? Pediatr Diabetes. 2003; 4:110-3.
Alberti G, Zimmet P, Shaw J et al. Type 2 diabetes in the young: the evolving epidemic: the International Diabetes Federation
Consensus Workshop. Diabetes Care. 2004; 27:1798-811.
Rizvi AA. Type 2 diabetes: epidemiologic trends, evolving pathogenic concepts, and recent changes in therapeutic approach.
South Med J. 2004; 97:1079-87.
Porter JR, Barrett TG. Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management. Arch Dis Child. 2004;
89:1138-44.
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005; 365:1415-28.
Umpierrez G, Korytkowski M. Diabetic emergencies – ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia.
Nat Rev Endocrinol. 2016; 12:222-32.
DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004; 88:787-835.
DeFronzo RA. Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes
mellitus. Diabetes. 2009; 58:773-95.
Carlsson S, Midthjell K, Grill V. Smoking is associated with an increased risk of type 2 diabetes but a decreased risk of
autoimmune diabetes in adults: an 11-year follow-up of incidence of diabetes in the Nord-Trondelag study. Diabetologia.
2004; 47:1953-6.
Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach.
Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes
(EASD). Diabetologia. 2012; 55:1577-96.
Tuomilehto J, Hu G, Bidel S et al. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and
women. JAMA. 2004; 291:1213-9.
Laws RA, St George AB, Rychetnik L et al. Diabetes prevention research: a systematic review of external validity in lifestyle
interventions. Am J Prev Med. 2012; 43:205-14.
Phillips DI. Birth weight and the future development of diabetes. A review of the evidence. Diabetes Care. 1998; 21(Suppl
2):B150-5.
Damm P. Future risk of diabetes in mother and child after gestational diabetes mellitus. Int J Gynaecol Obstet. 2009; 104(Suppl
1):S25-6.
Concha LL, Durruty PA, García de los Ríos MA. Diabetes mellitus tipo 2 con tendencia a la cetosis. Caso clínico. Rev Med
Chile. 2015; 143:1215-8.
Colloby M. Ketosis-prone diabetes: Identification and management. J Diabetes Nurs. 2014; 18:352-60.
Smiley D, Chandra P, Umpierrez G. Update on diagnosis, pathogenesis and management of ketosis prone type 2 diabetes
mellitus. Diabet Manag. 2011; 1:589-600.
Winter WE. Molecular and biochemical analysis of the MODY syndromes. Pediatr Diabetes. 2000; 1:88-117.
Oliveira SV, Furuzawa GK, Reis AF. Diabetes mellitus do tipo MODY. Arq Bras Endocrinol Metab. 2002; 46:186-92.
Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young.
N Engl J Med. 2001; 345:971-80.
Kim SH, Ma X, Weremowicz S et al. Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23.
Diabetes. 2004; 53:1375-84.
Costa A, Bescós M, Velho G et al. Genetic and clinical characterization of maturity-onset diabetes of the young in Spanish
families. Eur J Endocrinol. 2000; 142:380-6.
Massa O, Maxi F, Cuesta-Munoz A et al. High prevalence of glucoquinase mutations in Italian children with MODY. Influence
on glucose tolerance, first-phase insulina response, insulin sensitivity and BMI. Diabetologia. 2001; 44:898-905.
Hattersley AT. Maturity onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabetic Med.
1998; 15:15-24.
Reznik Y, Dao T, Coutant R et al. Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver
adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol
Metab. 2004; 89:1476-80.
	Endocrinologia Clinica - Vilar 6 edicao